NEUROPEPTIDE Y ACETATE MARKET ANALYSIS
Amgen, Inc., Phoenix Pharmaceuticals, Inc., Sigma Aldrich Corporation, Eli Lilly & Co, Pfizer, Inc., and Bachem Holding AG, Roche AG, Ipsen, Peptisyntha, Lonza, Inc., and Takeda Pharmaceuticals Company Limited are some of the key players in the global neuropeptide Y acetate market.
Key players in the market are focused on geographical and business expansion. For instance, in July 2018 – Bachem announced the establishment of a new entity in Tokyo, Japan named Bachem Japan K.K.
Similarly, in July 2018, Lonza Bioscience launched a new website: bioscience.lonza.com that offers detailed application and product information. The website is user friendly and mobile optimized.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
